182 related articles for article (PubMed ID: 27158463)
1. Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.
Mauvais FX; Diana J; van Endert P
F1000Res; 2016; 5():. PubMed ID: 27158463
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
3. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
van Lummel M; Zaldumbide A; Roep BO
Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
5. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
6. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes.
Bass LE; Bonami RH
Antibodies (Basel); 2024 Apr; 13(2):. PubMed ID: 38651407
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
8. An oral vaccine for type 1 diabetes based on live attenuated Salmonella.
Husseiny MI; Rawson J; Kaye A; Nair I; Todorov I; Hensel M; Kandeel F; Ferreri K
Vaccine; 2014 Apr; 32(20):2300-7. PubMed ID: 24631074
[TBL] [Abstract][Full Text] [Related]
9. The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes.
Purcell AW; Sechi S; DiLorenzo TP
Diabetes; 2019 May; 68(5):879-886. PubMed ID: 31010879
[TBL] [Abstract][Full Text] [Related]
10. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
11. Strategies for clinical trials in type 1 diabetes.
Ehlers MR
J Autoimmun; 2016 Jul; 71():88-96. PubMed ID: 27068279
[TBL] [Abstract][Full Text] [Related]
12. Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.
Marré ML; Piganelli JD
Front Endocrinol (Lausanne); 2017; 8():262. PubMed ID: 29033899
[TBL] [Abstract][Full Text] [Related]
13. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review.
Gomez-Tourino I; Arif S; Eichmann M; Peakman M
J Autoimmun; 2016 Jan; 66():7-16. PubMed ID: 26343335
[TBL] [Abstract][Full Text] [Related]
14. A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes.
Rodriguez-Fernandez S; Almenara-Fuentes L; Perna-Barrull D; Barneda B; Vives-Pi M
Immunol Cell Biol; 2021 May; 99(5):461-474. PubMed ID: 33483995
[TBL] [Abstract][Full Text] [Related]
15. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
[TBL] [Abstract][Full Text] [Related]
16. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
17. The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
Ben Nasr M; D'Addio F; Usuelli V; Tezza S; Abdi R; Fiorina P
Pharmacol Res; 2015 Aug; 98():31-8. PubMed ID: 25107501
[TBL] [Abstract][Full Text] [Related]
18. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
19. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
20. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
